Filter by: patients
Home > Community Treatment Reports and Side Effects > Mitoxantrone Treatment Report
What is Mitoxantrone?

Mitoxantrone is an antineoplastic agent used in the treatment of acute nonlymphocytic leukemia, prostate cancer, secondary progressive or relapsing-remitting MS. Off label it is used for certain lymphomas, certain adult and pediatric leukemias, myelodysplastic syndrome, breast cancer and sarcoma.

Reported Side Effects

Side effects as an overall problem

Severe
 12
Moderate
 20
Mild
 18
None
 15

Commonly reported side effects, conditions, and hospitalizations associated with Mitoxantrone

Tiredness 13
Nausea 10
Sick to my stomach 10
Hair loss (alopecia) 9
Headaches 7
Pain 6
See all 32 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Mitoxantrone. See all 33 dosages ►

  1other as needed 2mg/mL as needed 1g as needed 1 monthly 2 mg monthly 2 mg 14 mg every 3 months 20 mg every 3 months 2 mg one time 2 mg daily
  2 Number of Patients: 2 6 Number of Patients: 6 2 Number of Patients: 2 1 Number of Patients: 1 12 Number of Patients: 12 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 2 Number of Patients: 2 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Mitoxantrone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 84   Course of treatment ended: 40%
Doctor's advice 62   Doctor's advice: 29%
Did not seem to work 48   Did not seem to work: 23%
Side effects too severe 46   Side effects too severe: 22%
Other 18   Other: 9%
Personal research 6   Personal research: 3%
Expense 3   Expense: 1%
Not indicated 2   Not indicated: 1%
Change in health plan coverage 1   Change in health plan coverage: 0%

See all 199 patients who’ve stopped taking Mitoxantrone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Mitoxantrone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Mitoxantrone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Mitoxantrone

Always
 55 85%
Usually
 5 8%
Sometimes
 0 0%
Never
 5 8%

Burden

Difficulty being on treatment

Burden of Mitoxantrone

Very
 10 15%
Somewhat
 16 25%
A little
 14 22%
Not at all
 25 38%

Cost

Paid out of pocket

Cost of Mitoxantrone

$200+
 3 10%
$100-199
 4 13%
$50-99
 0 0%
$25-49
 0 0%
< $25
 23 77%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 09, 2012.